Followers | 35 |
Posts | 7503 |
Boards Moderated | 0 |
Alias Born | 02/15/2012 |
Tuesday, February 21, 2017 11:24:39 PM
pressure actually brings out the best in me; I'm working on trying to get he best out of myself without having to be at beer duress.
You must have missed where I said I could no longer update my position regularly....as I knew the game would be reaching a fever pitch.
I did sell my entire stake at .07; I needed a step back. I then repurchased at .08 after my internal review. I sold out at high .14s. I was not planning on re-enter, but when I saw the $1m private placement at the cost of 5% of MC vs 3% share ownership I figured I should get back in.
....in the end; I think I actually did make clear my positions though i had said I wouldn't....
The r/s issue is big for me. I find financial instruments incredibly intriguing.
At first I was on board with; "the issues weren't coincidenc", however I am less certain now.
I also have issue with FDA being a witness....or not...
In one month Cvm sold 20% of company (excluding warrants) for $4m cash; and 50% of company (including warrants) for a total upon exercise of ~$17-18m cash.
If I'm an investor I prefer to have major catalyst or speculation there of on then horizon. If the only thing ahead is a need of more cash for "marketing upon approval" or whatever it may be....isn't as enticing.
I.e. They do r/s now. All bad news (FDA, arb). They do recap with new investor; cash infusion alone brings market optimism.
They do r/s now. All good news.....optimism rains...with a new face.
I'm not certain r/s before....I have many arguments going both ways...including no r/s at all...
I'm really just trying to get somebody to say something that triggers me; whether it's to argree or disagree is irrelevant as I make my own decisions just like everybody.
Ps. I think a Big Bang trade is around the corner....not sure how long the corner is....
It's diagnostics. Trump trade....safety, fear, identify targets, who what can hurt us...fear, protection, identification....immigration ban of sorts....you think anybody throw a fit if we don't let people into the country of they have Zika? What you think about that?
Recent CVM News
- CEL-SCI Appoints Mario Gobbo to Its Board of Directors • Business Wire • 04/23/2024 01:00:00 PM
- CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology • Business Wire • 03/19/2024 01:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/07/2024 04:33:42 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/07/2024 04:33:13 PM
- CEL-SCI Corporation Issues Letter to Shareholders • Business Wire • 03/06/2024 01:45:00 PM
- CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results • Business Wire • 02/15/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:31:12 PM
- CEL-SCI Announces Closing of $7.75 Million Public Offering of Common Stock • Business Wire • 02/13/2024 05:00:00 PM
- CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock • Business Wire • 02/09/2024 01:30:00 PM
- CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug • Business Wire • 02/06/2024 02:00:00 PM
- European Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path Towards Marketing Authorization for Multikine® • Business Wire • 01/31/2024 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 02:06:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 02:03:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 02:00:11 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/22/2023 09:01:06 PM
- CEL-SCI Reports Fiscal 2023 Financial Results and Clinical & Corporate Developments • Business Wire • 12/22/2023 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/21/2023 09:15:39 PM
- UK’S National Institute for Health and Care Excellence (NICE) Selects CEL-SCI’s Multikine as Potential New Standard of Care for Head & Neck Cancer • Business Wire • 12/04/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 10:25:18 PM
- CEL-SCI Announces Closing of $5 Million Public Offering of Common Stock • Business Wire • 11/20/2023 09:15:00 PM
- CEL-SCI Announces Pricing of $5 Million Offering of Common Stock • Business Wire • 11/16/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 09:01:26 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM